These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 37987325)

  • 1. Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia.
    Dushianthan A; Bracegirdle L; Cusack R; Cumpstey AF; Postle AD; Grocott MPW
    Med Sci (Basel); 2023 Nov; 11(4):. PubMed ID: 37987325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual effects of supplemental oxygen on pulmonary infection, inflammatory lung injury, and neuromodulation in aging and COVID-19.
    Lin M; Stewart MT; Zefi S; Mateti KV; Gauthier A; Sharma B; Martinez LR; Ashby CR; Mantell LL
    Free Radic Biol Med; 2022 Sep; 190():247-263. PubMed ID: 35964839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19.
    Hanidziar D; Robson SC
    Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L12-L16. PubMed ID: 33050737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous sulforhodamine B reduces alveolar surface tension, improves oxygenation, and reduces ventilation injury in a respiratory distress model.
    Wu Y; Nguyen TL; Perlman CE
    J Appl Physiol (1985); 2021 May; 130(5):1305-1316. PubMed ID: 33211596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical ventilation in COVID-19: A physiological perspective.
    Cronin JN; Camporota L; Formenti F
    Exp Physiol; 2022 Jul; 107(7):683-693. PubMed ID: 34541721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury.
    Swenson KE; Swenson ER
    Crit Care Clin; 2021 Oct; 37(4):749-776. PubMed ID: 34548132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.
    Declercq J; Bosteels C; Van Damme K; De Leeuw E; Maes B; Vandecauter A; Vermeersch S; Delporte A; Demeyere B; Vuylsteke M; Lalla M; Smart T; Detalle L; Bouw R; Streffer J; Degeeter T; Vergotte M; Guisez T; Van Braeckel E; Van Der Straeten C; Lambrecht BN
    Trials; 2020 Nov; 21(1):934. PubMed ID: 33213529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of alveolar epithelial ER stress by β-coronavirus infection disrupts surfactant homeostasis in mice: implications for COVID-19 respiratory failure.
    Murthy A; Rodriguez LR; Dimopoulos T; Bui S; Iyer S; Chavez K; Tomer Y; Abraham V; Cooper C; Renner DM; Katzen JB; Bentley ID; Ghadiali SN; Englert JA; Weiss SR; Beers MF
    Am J Physiol Lung Cell Mol Physiol; 2024 Aug; 327(2):L232-L249. PubMed ID: 38860845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated FiO
    Myti D; Gunjak M; Casado F; Khaghani Raziabad S; Nardiello C; Vadász I; Herold S; Pryhuber G; Seeger W; Morty RE
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L670-L674. PubMed ID: 32878480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of respiratory failure at admission and in-hospital mortality in patients with COVID-19: a prospective observational multicentre study.
    Santus P; Radovanovic D; Saderi L; Marino P; Cogliati C; De Filippis G; Rizzi M; Franceschi E; Pini S; Giuliani F; Del Medico M; Nucera G; Valenti V; Tursi F; Sotgiu G
    BMJ Open; 2020 Oct; 10(10):e043651. PubMed ID: 33040020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation.
    Østergaard L
    Physiol Rep; 2021 Feb; 9(3):e14726. PubMed ID: 33523608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolized human extracellular superoxide dismutase prevents hyperoxia-induced lung injury.
    Yen CC; Lai YW; Chen HL; Lai CW; Lin CY; Chen W; Kuan YP; Hsu WH; Chen CM
    PLoS One; 2011; 6(10):e26870. PubMed ID: 22046389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive end-expiratory pressure in COVID-19 acute respiratory distress syndrome: the heterogeneous effects.
    Chiumello D; Bonifazi M; Pozzi T; Formenti P; Papa GFS; Zuanetti G; Coppola S
    Crit Care; 2021 Dec; 25(1):431. PubMed ID: 34915911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning-based analysis of alveolar and vascular injury in SARS-CoV-2 acute respiratory failure.
    Calabrese F; Pezzuto F; Fortarezza F; Boscolo A; Lunardi F; Giraudo C; Cattelan A; Del Vecchio C; Lorenzoni G; Vedovelli L; Sella N; Rossato M; Rea F; Vettor R; Plebani M; Cozzi E; Crisanti A; Navalesi P; Gregori D
    J Pathol; 2021 Jun; 254(2):173-184. PubMed ID: 33626204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.
    Gando S; Wada T
    Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic characteristics of alveolar-like macrophages in mouse models of hyperoxia and LPS-induced lung inflammation.
    Litman K; Bouch S; Litvack ML; Post M
    Am J Physiol Lung Cell Mol Physiol; 2024 Sep; 327(3):L269-L281. PubMed ID: 38887793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic blood oxygen indices in mechanically ventilated COVID-19 patients with acute hypoxic respiratory failure: A cohort study.
    Bracegirdle L; Jackson A; Beecham R; Burova M; Hunter E; Hamilton LG; Pandya D; Morden C; Grocott MPW; Cumpstey A; Dushianthan A;
    PLoS One; 2022; 17(6):e0269471. PubMed ID: 35687543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.